Pt Bundamedik Tbk · IDX:BMHS
Pt Bundamedik Tbk — H1 2024 Earnings Presentation
20 slides from Pt Bundamedik Tbk's earnings presentation, August 2024
Slide 1: PT Bundamedik Tbk Analyst Meeting – 1H24 Results
PT Bundamedik Tbk Analyst Meeting – 1H24 Results Aug 2024
Slide 2: Leading Provider in Specialized Healthcare Services since 1973
Leading Provider in Specialized Healthcare Services since 1973
Slide 3: Bundamedik Tbk (BMHS) Ecosystem
Bundamedik Tbk (BMHS) Ecosystem Expanding Presence RSIA Az Zahra 10 HOSPITALS Women & Children Hospitals 12 IVF CLINICS PADANG PONTIANAK BATAM 25 LABORATORIES Bunda Hospitals PALEMBANG MAKASSAR CLINICS NETWORK 1k++ (KLINIK PINTAR) YOGYAKARTA 126 FERTILITY CLINICS NETWORK (KFI) Jakarta Depok BANDUNG
Slide 4: 2Q24 Key Highlights
2Q24 Key Highlights 1 2 Consol Revenue Consolidated Gross Margin +10% +9% vs 2Q23 vs 1H23 56% +16% # of Outpatients Higher +2% vs 2Q23 and +17% +36% # of IP Days +38% Higher +1% vs 1H23 +10% # of Surgeries +11% +26% # of Lab Tests +30% 3 4 EBITDA New Hospitals +68% +34% +72% Net Revenue vs 2Q23 vs 1
Slide 5: 1H24 Results
@punva fp Piagnes | morvieyi «= SSBGP Paiccunic ERE OBO Pax, Ts, SEYNCA
Slide 6: Financial & Operational Performance
Financial & Operational Performance HIGHLIGHTS OF CONSOLIDATED RESULT Key Notes 2Q23 2Q24 YoY (%) 1H23 1H24 YoY (%) 1 OPERATIONALS ('000) 1 Core Business in 1H24 # Outpatient 128.3 148.3 16% 262.2 306.8 17% • Hospitals metrics: Overall positive growth in #Outpatients, #IP Admission, #Surgery, and #I
Slide 7: Hospitals Volume
Hospitals Volume # OUTPATIENTS # IP ADMISSION +20% 565.6 +17% 42.9 41.0 42.0 41.6 +41% 4.5 4.2 36.7 38.6 +21% 4.0 3.8 485.7 42.5 3.8 3.6 390.5 34.4 262.2 306.8 21.3 23.9 19.9 2021 2022 2023 1H23 1H24 Jan-24 Feb-24 Mar-24 Apr-24 May-24 Jun-24 2021 2022 2023 1H23 1H24 Jan-24 Feb-24 Mar-24 Apr-24 May-2
Slide 8: Financial Performance
Financial Performance Consolidated NET REVENUE EBITDA EBITDA Margin Net Core Revenue (Rp B) (Rp B,% Margin) Covid EBITDA Net Covid Revenue Core EBITDA 34% +9% +55% 806 720 16% 671 24% 3% 22% 618 21% 272 18% 434 361 169 15% 97% 117 19 84% 100% 100% 80 123 100% 93 3 92 96% 155 151 93 123 77 92 1H19 1H
Slide 9: Balance Sheet
Balance Sheet Remains healthy CASH VS DEBT NET DEBT-TO-EBITDA (Rp B) (x) Net 418 -135 -216 225 405 562 Debt 1,144 2.2x 1,027 1.9x 2.3x 830 855 0.7x 625 613 629 622 582 518 490 100 -0.6x -0.4x 2019 2020 2021 2022 2023 1H24 2019 2020 2021 2022 2023 1H24 AR Days WORKING CAPITAL DAYS Inventory Days 58 5
Slide 10: IVF Cycles
IVF Cycles # OF IVF CYCLES (‘000) Improved compared to pre-Covid era +14% 3,07 2,80 2,52 2,53 2,23 1,62 1H19 1H20 1H21 1H22 1H23 1H24
Slide 11: Diagnos
Diagnos Focusing on genomic testing # OF TESTS (‘000) Covid Non Covid +30% +30% 435 433 YoY Number of 375 334 Test Volume 1% 30% 32% 7% 99% 68% 70% 93% 1H21 1H22 1H23 1H24 Promising Genomic revenue YoY increased by 40% YoY, contributing REVENUE (in bn rupiah) Covid Revenue Genomic Revenue Others Tes
Slide 12: Strengthening Our Core
Strengthening Our Core @punva fp Piagnes | morvieyi «= SSBGP Paiccunic ERE OBO Pax, Ts, SEYNCA
Slide 13: Strengthening Our COEs
Strengthening Our COEs GynROSE Clinic Robotic Surgery Bunda Neuro Center Eras NICU/PICU Laparoskopi Bunda Health Center RSM Oncology Bunda General Hospital Bunda Women & Children Hospital Jakarta Klinik Tumbuh Kembang Anak Bunda Endoscopy Center
Slide 14: Update Hospitals Result Initiatives
Update Hospitals Result Initiatives Revenue Per payor: 1Q23 1H23 1H24 Hospitals improvement perspective: • Increased +3pps in BPJS payor as our new hospitals 20% mainly serves BPJS BPJS 23% • There is a +2pps improvement in BPJS Margin from OOP 41% 41% 32% in 1H23 to 34% in 1H24 Corp & Ins • Bunda w
Slide 15: Ensuring Standardized Quality Process
Ensuring Standardized Quality Process
Slide 16: 2024 Update & Initiatives
2024 Update & Initiatives @punva fp Piagnes | morvieyi «= SSBGP Paiccunic ERE OBO Pax, Ts, SEYNCA
Slide 17: 2024 Key Initiatives
2024 Key Initiatives 1 2 3 Improving overall medical Optimize and standardize Central procurement for services, facilities, branding pricing guideline pharma and consumables and patient experience 4 5 Implement data integration Establish culture and throughout BMHS group employee engagement
Slide 18: 2024 One Bunda
2024 One Bunda 251.210 (Existing Non-BPJS Patients) As of 30 June 2024, 41% Of existing Bunda's patients (non BPJS) have registered and used OneBunda Most Frequently Used Features is Janji Temu that generate ~99K Transactions 102.995 OneBunda’s Unique Users
Slide 19: 2024 Update Strategic Partnership Morula x Jinxin Fertility
2024 Update Strategic Partnership Morula x Jinxin Fertility Signing Agreement Proforma Shareholding at Morula Morula Share Pre- Pre-Transaction Post- Post-Transaction Ownership Transaction Value Transaction Value BMHS 63,00% Rp. 630.000.000.000 47,25% Rp. 661.180.333.333 PT Bunda Ipiti 37,00% Rp. 37
Slide 20: PT Bundamedik Tbk
PT Bundamedik Tbk Jl. Teuku Cik Ditiro No. 28, Menteng, Jakarta 10350 – Indonesia (62-21) 3192-3344